<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosntds</journal-id>
<journal-title-group>
<journal-title>PLOS Neglected Tropical Diseases</journal-title>
</journal-title-group>
<issn pub-type="epub">1935-2735</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pntd.0005268</article-id>
<article-id pub-id-type="publisher-id">PNTD-D-16-01677</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Liver diseases</subject><subj-group><subject>Liver fibrosis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Helminths</subject><subj-group><subject>Schistosoma</subject><subj-group><subject>Schistosoma japonicum</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Organism development</subject><subj-group><subject>Aging</subject><subj-group><subject>Senescence</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Aging</subject><subj-group><subject>Senescence</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Aging</subject><subj-group><subject>Senescence</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Specimen preparation and treatment</subject><subj-group><subject>Staining</subject><subj-group><subject>Cell staining</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Molecular biology assays and analysis techniques</subject><subj-group><subject>Gene expression and vector techniques</subject><subj-group><subject>Protein expression</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Molecular biology assays and analysis techniques</subject><subj-group><subject>Gene expression and vector techniques</subject><subj-group><subject>Protein expression</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>DNA construction</subject><subj-group><subject>Plasmid construction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>DNA construction</subject><subj-group><subject>Plasmid construction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell processes</subject><subj-group><subject>Cell cycle and cell division</subject><subj-group><subject>Cell cycle inhibitors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>Gene regulation</subject><subj-group><subject>Small interfering RNAs</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>RNA</subject><subj-group><subject>Non-coding RNA</subject><subj-group><subject>Small interfering RNAs</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Soluble Egg Antigens of <italic>Schistosoma japonicum</italic> Induce Senescence of Activated Hepatic Stellate Cells by Activation of the FoxO3a/SKP2/P27 Pathway</article-title>
<alt-title alt-title-type="running-head">Soluble Egg Antigens of <italic>Schistosoma japonicum</italic> Induce Senescence of Activated Hepatic Stellate Cells</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5824-5762</contrib-id>
<name name-style="western">
<surname>Duan</surname>
<given-names>Yinong</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Pan</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Jinling</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhu</surname>
<given-names>Dandan</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Jianxin</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Sun</surname>
<given-names>Xiaolei</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Liuting</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Liting</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Pathogen Biology, School of Medicine, Nantong University, Nantong, Jiangsu, People’s Republic of China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Pathogen Biology and Immunology, Kangda College of Nanjing Medical University, Lianyungang, Jiangsu, People’s Republic of China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Laboratory Medicine Center, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People’s Republic of China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Donnelly</surname>
<given-names>Sheila M.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Technology, Sydney, AUSTRALIA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item><p><bold>Conceptualization:</bold> YD JC.</p></list-item> <list-item><p><bold>Data curation:</bold> YD JP JC DZ.</p></list-item> <list-item><p><bold>Formal analysis:</bold> JP DZ JW.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> YD JC DZ.</p></list-item> <list-item><p><bold>Investigation:</bold> JP JC.</p></list-item> <list-item><p><bold>Methodology:</bold> JP DZ JW LW.</p></list-item> <list-item><p><bold>Project administration:</bold> YD JC DZ.</p></list-item> <list-item><p><bold>Resources:</bold> YD JC DZ JW XS.</p></list-item> <list-item><p><bold>Software:</bold> XS LC.</p></list-item> <list-item><p><bold>Supervision:</bold> YD.</p></list-item> <list-item><p><bold>Validation:</bold> YD JP JC.</p></list-item> <list-item><p><bold>Visualization:</bold> JC.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> JP.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> YD JC.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">yinongduan@aliyun.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2016</year>
</pub-date>
<volume>10</volume>
<issue>12</issue>
<elocation-id>e0005268</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Duan et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pntd.0005268"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Liver fibrosis was viewed as a reversible process. The activation of hepatic stellate cells (HSCs) is a key event in the process of liver fibrosis. The induction of senescence of HSCs would accelerate the clearance of the activated HSCs. Previously, we demonstrated that soluble egg antigens (SEA) of <italic>Schistosoma japonicum</italic> promoted the senescence of HSCs via STAT3/P53/P21 pathway. In this paper, our study was aimed to explore whether there are other signaling pathways in the process of SEA-induced HSCs aging and the underlying effect of SKP2/P27 signal on senescent HSCs.</p>
</sec>
<sec id="sec002">
<title>Methodology/Principal findings</title>
<p>Human hepatic stellate cell line, LX-2 cells, were cultured and stimulated with SEA. Western blot and cellular immunofluorescence analysis were performed to determine the expression of senescence-associated protein, such as P27, SKP2 and FoxO3a. Besides, RNA interfering was applied to knockdown the expression of related protein. The senescence of HSCs was determined by senescence-associated β-gal staining. We found that SEA increased the expression of P27 protein, whereas it inhibited the expression of SKP2 and FoxO3a. Knockdown of P27 as well as overexpression of SKP2 both suppressed the SEA-induced senescence of HSCs. In addition, the nuclear translocation of FoxO3a from the nucleus to the cytoplasm was induced by SEA stimulation.</p>
</sec>
<sec id="sec003">
<title>Conclusions/Significance</title>
<p>The present study demonstrates that SEA promotes HSCs senescence through the FoxO3a/SKP2/P27 pathway.</p>
</sec>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<p>Activation of hepatic stellate cells (HSCs) is a key event of liver fibrosis. Induction of activated HSCs apoptosis and inhibition of activated HSCs proliferation are the common anti-fibrotic strategies to block liver fibrosis. The induction of senescence of HSCs is responsible for the clearance of the activated HSCs as well. Senescence of HSCs is mediated by exposure to soluble egg antigens (SEA) of <italic>Schistosoma japonicum</italic> via STAT3/P53/P21 pathway. In this study, we found that SEA induced the senescence of HSCs, accompanied with the increased the expression of P27 protein and the decreased expression of SKP2 and FoxO3a. Either knockdown of P27 or overexpression of SKP2 alleviates the SEA-induced senescence of HSCs. Moreover, SEA droved the nuclear translocation of FoxO3a from the nucleus to the cytoplasm. Hence, the present study demonstrates that SEA promotes HSCs senescence through the FoxO3a/SKP2/P27 pathway.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>81471975</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5824-5762</contrib-id>
<name name-style="western">
<surname>Duan</surname>
<given-names>Yinong</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>81401683</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Chen</surname>
<given-names>Jinling</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>81501763</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Zhu</surname>
<given-names>Dandan</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>81171589</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5824-5762</contrib-id>
<name name-style="western">
<surname>Duan</surname>
<given-names>Yinong</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award005">
<funding-source>
<institution>the Jiangsu provincial Natural Science Foundation</institution>
</funding-source>
<award-id>BK20140435</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Chen</surname>
<given-names>Jinling</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award006">
<funding-source>
<institution>the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)</institution>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5824-5762</contrib-id>
<name name-style="western">
<surname>Duan</surname>
<given-names>Yinong</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by National Natural Science Foundation of China (Grant Numbers 81471975, 81401683, 81501763, 81171589), the Jiangsu provincial Natural Science Foundation (Grant Number BK20140435), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<page-count count="11"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2017-01-12</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec004" sec-type="intro">
<title>Introduction</title>
<p>Liver fibrosis, a major health problem worldwide [<xref ref-type="bibr" rid="pntd.0005268.ref001">1</xref>], results from different etiologies of chronic liver injury, and eventually progresses into cirrhosis or hepatocellular carcinoma. Recently, liver fibrosis was viewed as a reversible process [<xref ref-type="bibr" rid="pntd.0005268.ref002">2</xref>]. After years of prevention and treatment of schistosomiasis in China, the new cases of <italic>Schistosoma</italic> infection have declined significantly, but there are still thousands of patients suffering from schistosomiasis [<xref ref-type="bibr" rid="pntd.0005268.ref003">3</xref>]. The main pathological change of schistosomiasis is the formation of granuloma around the eggs of <italic>Schistosoma japonicum</italic> (<italic>S</italic>. <italic>japonicum</italic>) in the liver, leading to liver fibrosis.</p>
<p>Studies indicate that the activation of hepatic stellate cells (HSCs) is a key event in the process of liver fibrosis. HSCs are activated and then transform to myofibroblasts, once the liver is subjected to stimulations. Activated HSCs synthesize large amounts of extracellular matrix proteins (ECM) such as type I or type III collagen, laminin and fibronectin [<xref ref-type="bibr" rid="pntd.0005268.ref004">4</xref>]. In the process of liver fibrosis induced by <italic>S</italic>. <italic>japonicum</italic> infection, HSCs gather around <italic>S</italic>. <italic>japonicum</italic> egg granuloma [<xref ref-type="bibr" rid="pntd.0005268.ref005">5</xref>]. Activated HSCs can express a variety of inhibitors of metalloproteinases (TIMPs) to prevent the degradation of matrix proteins, resulting in the replacement of normal liver tissue by collagen matrix and the formation of fibrous scar. Therefore, inhibition of the HSCs activation, proliferation and accelerating the clearance of the activated HSCs are key strategies for the prevention and treatment of liver fibrosis [<xref ref-type="bibr" rid="pntd.0005268.ref006">6</xref>].</p>
<p>Substantial evidences support the possibility of the reversibility of liver fibrosis [<xref ref-type="bibr" rid="pntd.0005268.ref002">2</xref>]. Recently, studies revealed that with the development of pathologic process, the size of egg granulomas at the chronic phase (12 weeks) and the advanced phase (24 weeks) was smaller than that at the acute phase of <italic>S</italic>. <italic>japonicum</italic> egg-induced liver fibrosis [<xref ref-type="bibr" rid="pntd.0005268.ref007">7</xref>]. Researches indicate that the reversion of liver fibrosis is closely related to the increase of the apoptosis of HSCs. Expression of the tissue inhibitor of metalloproteinase-1 (TIMP-1) decreased, and the synthesis of metalloproteinases (MMPs) such as MMP-1 and MMP-13 increased, thereby inhibiting HSCs activation and proliferation, increasing the clearance of activated HSCs as well as the degradation of collagen fiber, and eventually alleviating liver fibrosis [<xref ref-type="bibr" rid="pntd.0005268.ref008">8</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref009">9</xref>].</p>
<p>Studies showed that the induction of senescence of HSCs would accelerate the clearance of the activated HSCs as well [<xref ref-type="bibr" rid="pntd.0005268.ref010">10</xref>]. The senescent cells usually display a cell cycle arrest in the G0 or G1 phase but maintain the metabolic activity [<xref ref-type="bibr" rid="pntd.0005268.ref011">11</xref>]. Once senescent, senescence-associated β-gal (SA-β-Gal), the specific maker of senescence, is detected in these cells. In our previous study, we demonstrated that SEA induced the HSCs senescence through the STAT3/P53/P21 pathway [<xref ref-type="bibr" rid="pntd.0005268.ref012">12</xref>]. Besides, it has been well established that FoxO3a signaling cascade is implicated in the senescent process of multiple cells [<xref ref-type="bibr" rid="pntd.0005268.ref013">13</xref>–<xref ref-type="bibr" rid="pntd.0005268.ref015">15</xref>]. It has been revealed that FoxO3a inhibited the senescence of hepatocytes [<xref ref-type="bibr" rid="pntd.0005268.ref016">16</xref>]. Additionally, S phase kinase associated protein 2 (SKP2) was reported to suppress cellular senescence induced by oncogenic stimuli independent of ARF/p53 signaling. And cell cycle inhibitor P27, the SKP2 substrate, is targeted by SKP2 for ubiquitination and degradation [<xref ref-type="bibr" rid="pntd.0005268.ref017">17</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref018">18</xref>]. In this study, we investigate whether the FoxO3a/SKP2/P27 signaling participates in the SEA-induced HSCs senescence.</p>
</sec>
<sec id="sec005" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec006">
<title>Reagents</title>
<p>SEA of <italic>S</italic>. <italic>japonicum</italic> were obtained from Jiangsu Institute of Parasitic Diseases (China). SEA was sterile-filtered and endotoxin was removed with Polymyxin B agarose beads (Sigma, USA). Limulus amebocyte lysate assay kit (Lonza, Switzerland) was used to confirm the removal of endotoxins from the SEA as previously described [<xref ref-type="bibr" rid="pntd.0005268.ref019">19</xref>]. Primary antibodies for FoxO3a, SKP2, P27 and AKT were purchased from Santa Cruz Biotechnology (USA, antibody dilution for Western blot of all antibodies from this company is 1:200). Primary antibody for phospho-AKT was purchased from Cell Signaling Technology (USA, antibody dilution for Western blot is 1:1000). All of the secondary antibodies were obtained from Santa Cruz Biotechnology (USA, antibody dilution is 1:2000). The staining kit for SA-β-Gal was purchased from GenMed Scientifics Inc (USA).</p>
</sec>
<sec id="sec007">
<title>Culture of human hepatic stellate cell line LX-2</title>
<p>LX-2 cells, the ‘immortalised’ human HSCs, were provided by Xiangya Central Experiment Laboratory (Hunan, China) and maintained in DMEM with 10% Fetal Bovine Serum in a humidified incubator with 5% CO<sub>2</sub>. Culture medium was replaced every day and cells were subcultured with trypsin when they were at 80% confluence.</p>
</sec>
<sec id="sec008">
<title>Western blot</title>
<p>Cells were lysed in RIPA cell lysis buffer including protease inhibitor (1mM) and phosphatase inhibitors (1mM). Equal amounts of protein extract were separated by SDS-PAGE and then transferred onto polyvinylidene difluoride (PVDF) membranes. The membranes were blocked in 5% nonfat milk for 2 hours, incubated with the indicated primary antibodies at 4°C overnight, and then incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 hour at room temperature.</p>
</sec>
<sec id="sec009">
<title>SA-β-Gal staining</title>
<p>SA-β-Gal staining was performed according to the instruction of SA-β-Gal staining kit, in which cleaning solution, fixation fluid, acidic solution and staining fluid were provided as the main kit contents. Briefly, LX-2 cells were washed with cleaning solution and fixed by fixation fluid for 5 minutes at room temperature. Afterwards, cells were washed by acidic solution twice and stained with staining fluid for 16 hours at 37°C. Finally, SA-β-Gal staining positive cells were assayed using a bright field microscope.</p>
</sec>
<sec id="sec010">
<title>Immunofluorescence analysis</title>
<p>For the Immunofluorescence staining, cells were seeded in 6-well culture plates and fixed with 4% paraformaldehyde. Afterwards, cells were permeabilized with 0.1% Triton X-100 and then blocked in 5% BSA. After that, cells were incubated with FoxO3a antibody (dilution is 1:50) and visualized with Alexa Fluor 568 conjugated secondary antibody (Invitrogen, USA, antibody dilution is 1:200) under a fluorescent microscopy.</p>
</sec>
<sec id="sec011">
<title>Vector construction</title>
<p>pcDNA3.1 plasmid was digested with <italic>EcoR</italic>I and <italic>BamH</italic>I (TaKaRa, China), and CDS region of SKP2 (GenBank: NM_005983) was subcloned into pcDNA3.1 vector to generate the recombinant vector pcDNA3.1-SKP2. The recombinant plasmids were verified by restriction analysis and sequencing.</p>
</sec>
<sec id="sec012">
<title>Cell transfection</title>
<p>LX-2 cells were transfected with P27 siRNA (GenePharma, China) or pcDNA3.1-SKP2 overexpression plasmid by Lipofectamine 2000 reagents (Invitrogen, USA) according to the manufacturer’s instructions. After 24 hours, cells were subjected to various stimulations for indicated time.</p>
</sec>
<sec id="sec013">
<title>Statistical analysis</title>
<p>Data is expressed as mean ± SEM (standard error of mean) of three independent experiments. All <italic>p</italic> values were calculated using a two tailed paired Student’s t test or a one way ANOVA. <italic>p</italic> &lt; 0.05 was considered as statistically significant.</p>
</sec>
</sec>
<sec id="sec014" sec-type="results">
<title>Results</title>
<sec id="sec015">
<title>SEA-induced LX-2 cells senescence is related to the P27 signaling pathway</title>
<p>Previously, we found that SEA-induced LX-2 cells senescence via the STAT3/P53/P21 pathway [<xref ref-type="bibr" rid="pntd.0005268.ref011">11</xref>]. Since P27, the cell cycle inhibitor, plays an important role in cellular senescence and SKP2 could cause a decrease in the level of P27 expression [<xref ref-type="bibr" rid="pntd.0005268.ref013">13</xref>, <xref ref-type="bibr" rid="pntd.0005268.ref020">20</xref>], we next verified whether P27 signaling pathway is implicated in the progress of LX-2 senescence. As illustrated in <xref ref-type="fig" rid="pntd.0005268.g001">Fig 1</xref>, Western blot analysis showed that SEA markedly increased the expression of P27, but decreased the SKP2 protein level. Furthermore, the expression of P-AKT, the upstream of P27, was also significantly decreased under SEA exposure, although the total expression of AKT was not affected.</p>
<fig id="pntd.0005268.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0005268.g001</object-id>
<label>Fig 1</label>
<caption>
<title>SEA-induced LX-2 cells senescence is related to the P27 signaling pathway.</title>
<p>Expression of P27, SKP2, total AKT and P-AKT were assayed by Western blot. * <italic>p</italic>&lt;0.05, compared to control group; # <italic>p</italic>&gt;0.05, compared to control group.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0005268.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec016">
<title>FoxO3a is implicated in the SEA-induced LX-2 cells senescence</title>
<p>Apart from the regulation of the level of P27 by SKP2, P27 is also regulated by the FoxO3a protein at the transcriptional level [<xref ref-type="bibr" rid="pntd.0005268.ref014">14</xref>]. Also, FoxO3a could be regulated by AKT and 14-3-3 protein [<xref ref-type="bibr" rid="pntd.0005268.ref021">21</xref>]. Thus, we further investigated whether FoxO3a was involved in the senescence of LX-2 cells induced by SEA. The results of Western blot indicated that FoxO3a was significantly inhibited by SEA stimulation in the LX-2 cells (<xref ref-type="fig" rid="pntd.0005268.g002">Fig 2A</xref>). Besides, cell immunofluorescence assay confirmed that FoxO3a was transferred from the nucleus to the cytoplasm after SEA treatment (<xref ref-type="fig" rid="pntd.0005268.g002">Fig 2B</xref> and <xref ref-type="supplementary-material" rid="pntd.0005268.s001">S1 Fig</xref>). These results suggested that FoxO3a was implicated in the SEA-induced senescence in LX-2 cells.</p>
<fig id="pntd.0005268.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0005268.g002</object-id>
<label>Fig 2</label>
<caption>
<title>FoxO3a is implicated in the SEA-induced LX-2 cells senescence.</title>
<p>(A) The expression of FoxO3a was assayed using Western blot. (B) Nuclear accumulation of FoxO3a was detected by immunofluorescence staining. Compared to the control group, ** <italic>p</italic>&lt;0.01; Bar: 50 μm.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0005268.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>SEA-mediated LX-2 senescence is dependent on P27</title>
<p>In order to further verify the role of P27 in the SEA-induced senescence in LX-2 cells, P27 specific small interfering RNA was used to knockdown the expression level of P27 protein in LX-2 cells. As illustrated in <xref ref-type="fig" rid="pntd.0005268.g003">Fig 3</xref>, the SA-β-Gal staining showed that the senescent LX-2 cells significantly increased accompanied with the upregulated P27 upon SEA stimulation. Nevertheless, the senescence of LX-2 cells induced by SEA was reversed by the P27 siRNA. These results suggest that P27 is a key regulator in the senescence of LX-2 cells induced by SEA.</p>
<fig id="pntd.0005268.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0005268.g003</object-id>
<label>Fig 3</label>
<caption>
<title>SEA-mediated LX-2 senescence is dependent on P27.</title>
<p>(A) The expression of P27 and SKP2 was detected by Western blot in LX-2 cells treated with SEA or P27 siRNA, respectively. * <italic>p</italic>&lt;0.05, compared to control group; $ <italic>p</italic>&lt;0.05, compared to Si-Con group; &amp; <italic>p</italic>&lt;0.05, compared to control group; φ <italic>p</italic>&lt;0.05, compared to Si-P27 group. (B) After treatment of SEA or P27 siRNA, cell senescence phenotype was assayed by SA-β-Gal staining. The proportion of SA-β-Gal staining positive cells was calculated. *** <italic>p</italic>&lt;0.001; * <italic>p</italic>&lt;0.05. Bar: 50 μm.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0005268.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec018">
<title>SEA promotes LX-2 cells senescence in a SKP2 dependent manner</title>
<p>Studies indicate that SKP2 plays an important role in the process of cellular senescence [<xref ref-type="bibr" rid="pntd.0005268.ref017">17</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref020">20</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref022">22</xref>], thus, we explored whether SKP2 is a regulator in the SEA-induced senescence in LX-2 cells. We found that SEA inhibited the expression of SKP2 (<xref ref-type="fig" rid="pntd.0005268.g001">Fig 1</xref>). In order to further investigate the potential mechanism of SKP2 in the process of SEA-induced senescence, specific SKP2 over expression plasmid was constructed and transfected into LX-2 cells, and then the efficiency was confirmed by Western blot analysis. The results showed that the SKP2 protein expression in LX-2 cells was enhanced after transfection with SKP2 over expression plasmid (<xref ref-type="fig" rid="pntd.0005268.g004">Fig 4A</xref>), and the high expression of SKP2 could inhibit the senescence of LX-2 cells induced by SEA (<xref ref-type="fig" rid="pntd.0005268.g004">Fig 4B</xref>). These results suggest that SKP2 can inhibit LX-2 cells senescence mediated by SEA.</p>
<fig id="pntd.0005268.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0005268.g004</object-id>
<label>Fig 4</label>
<caption>
<title>SEA promotes LX-2 cells senescence in a SKP2 dependent manner.</title>
<p>(A) The expression of SKP2 and P27 was assayed by Western blot in LX-2 cells treated with SEA or SKP2 over expression plasmid. * <italic>p</italic>&lt;0.05, compared to control group; $ <italic>p</italic>&lt;0.05, compared to empty vector group; &amp; <italic>p</italic>&lt;0.05, compared to control group; # <italic>p</italic>&gt;0.05, compared to SKP2 vector group. (B) SA-β-Gal staining was used to detect cell senescence phenotype after treatment with SEA or SKP2 over expression plasmid, and the proportion of SA-β-Gal staining positive cells was calculated. *** <italic>p</italic>&lt;0. 001; # <italic>p</italic>&gt;0.05. Bar: 50 μm.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0005268.g004" xlink:type="simple"/>
</fig>
<p>To explore the mechanism of SKP2 on senescence in LX-2 cells, we also examined the expression of P27, and we found that the expression of P27 in LX-2 cells was significantly restricted after the overexpression of SKP2 (<xref ref-type="fig" rid="pntd.0005268.g004">Fig 4A</xref>). On the contrary, the expression of SKP2 in LX-2 cells was not affected by the knockdown of P27 expression (<xref ref-type="fig" rid="pntd.0005268.g003">Fig 3A</xref>).</p>
</sec>
</sec>
<sec id="sec019" sec-type="conclusions">
<title>Discussion</title>
<p>It has been well accepted that activation of quiescent HSCs is responsible for the excessive production of ECM in liver fibrosis [<xref ref-type="bibr" rid="pntd.0005268.ref023">23</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref024">24</xref>], and there has been increased recognition in utilizing functions of HSCs for therapeutic applications to reverse liver fibrosis [<xref ref-type="bibr" rid="pntd.0005268.ref025">25</xref>]. Thus, preventing the activation of HSCs and increasing the clearance of activated HSCs are viewed as promising anti-fibrotic strategies [<xref ref-type="bibr" rid="pntd.0005268.ref004">4</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref026">26</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref027">27</xref>]. Among these, induction of activated HSCs apoptosis and inhibition of activated HSCs proliferation are the common anti-fibrotic strategies to block liver fibrosis. For example, we found SEA could induce HSC apoptosis and inhibit activation of HSCs under some suitable conditions [<xref ref-type="bibr" rid="pntd.0005268.ref019">19</xref>]. In addition, studies showed that the senescence of HSCs would block the development of liver fibrosis. Kong X et al. have demonstrated that IL-22 induced HSCs senescence and restricted the development of liver fibrosis in mice [<xref ref-type="bibr" rid="pntd.0005268.ref010">10</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref028">28</xref>,<xref ref-type="bibr" rid="pntd.0005268.ref029">29</xref>]. Which are different from quiescent HSCs, senescent HSCs often manifest as SA-β-Gal staining positive cells. In the previous study, our results showed that more SA-β-Gal staining positive cells could be found in SEA-treated LX-2 cells and SEA decreased the expression of α-SMA in LX-2 cells partially due to SEA-induced senescence [<xref ref-type="bibr" rid="pntd.0005268.ref011">11</xref>].</p>
<p>It has been shown that P53, tumor suppressor protein, plays a critical role in the induction of senescence. We have recently shown that SEA induced HSCs senescence through STAT3/P53/P21 pathway. SEA increased the expression of P-STAT3, P53 and P21. And knockdown of STAT3 or P53 inhibited the SEA-induced senescence of HSCs [<xref ref-type="bibr" rid="pntd.0005268.ref012">12</xref>]. Besides the P53-P21 and P16-Rb signaling pathways [<xref ref-type="bibr" rid="pntd.0005268.ref030">30</xref>–<xref ref-type="bibr" rid="pntd.0005268.ref032">32</xref>], there are other signaling pathways that promoting the development and progression of cellular senescence. The inactivation of retinal vascular tumor suppressor factor (VHL) can decrease the expression of SKP2 and increase the expression of P27, and then induce cellular senescence [<xref ref-type="bibr" rid="pntd.0005268.ref033">33</xref>]. Consistent with this result, the overexpression of HTLV-1 Tax protein also reduced the expression of SKP2 and accompanied with the occurrence of cellular senescence in human T cells [<xref ref-type="bibr" rid="pntd.0005268.ref034">34</xref>]. These results suggest that the decrease of SKP2 and the induction of P27 might play direct roles in cellular senescence. SKP2 is a member of the F box protein family, and the formation of the SKP2-SCF complex exhibits the E3 ligase activity. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Li%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26942878" xlink:type="simple">Li Z</ext-link> et al. showed that SKP2 regulates cell cycle and cell proliferation by degradation of its downstream molecules such as P27, a cell cycle inhibitor [<xref ref-type="bibr" rid="pntd.0005268.ref035">35</xref>–<xref ref-type="bibr" rid="pntd.0005268.ref037">37</xref>]. And recent studies have shown that inactivation of SKP2 induces cellular senescence, in which the cell cycle inhibitor P27 and P21 expression are enhanced [<xref ref-type="bibr" rid="pntd.0005268.ref017">17</xref>]. Therefore, we suspect that SKP2 is involved in the process of SEA-induced LX-2 cell senescence. We found that SEA markedly inhibited the expression of SKP2, but enhanced expression of P27 (<xref ref-type="fig" rid="pntd.0005268.g001">Fig 1</xref>). In order to further verify the role of SKP2 and P27 in the senescence of LX-2 cells, we transfected P27 siRNA to LX-2 cells to knockdown the P27 protein expression and transfected SKP2 overexpression plasmid to upregulate the expression of SKP2. These results further confirmed that SEA-induced cellular senescence was partially dependent of SKP2/P27 pathway (<xref ref-type="fig" rid="pntd.0005268.g003">Fig 3</xref> and <xref ref-type="fig" rid="pntd.0005268.g004">Fig 4</xref>).</p>
<p>In addition to the regulation of the post transcriptional level of P27 by SKP2, P27 is also regulated by the FoxO3a protein at the transcriptional level [<xref ref-type="bibr" rid="pntd.0005268.ref014">14</xref>]. The data shows that FoxO3a participates in the process of many kinds of cell senescence. Xu-Feng et al. found that FoxO3a can inhibit the senescence of cardiovascular endothelial cells by regulating the cell cycle mediated by ROS [<xref ref-type="bibr" rid="pntd.0005268.ref014">14</xref>]. Similarly, in the experiment of Kyoung Kim H et al., FoxO3a also exhibited an inhibition effect on human dermal fibroblast senescence. The experimental results demonstrated that knockdown of FoxO3a could promote the cell senescence [<xref ref-type="bibr" rid="pntd.0005268.ref038">38</xref>]. Therefore, we further verify the effect of FoxO3a on the senescence of SEA-induced LX-2 cells, and our experimental results are consistent with the above phenomena. In SEA-treated LX-2 cells, FoxO3a protein expression was significantly inhibited, and FoxO3a occurred nuclear transfer from the nucleus to the cytoplasm under the role of SEA (<xref ref-type="fig" rid="pntd.0005268.g002">Fig 2B</xref>). Thus, FoxO3a is a key regulator in the SEA-induced senescence of LX-2 cells.</p>
<p>To our knowledge, AKT kinases are critical players in PI3K-mediated signal transduction pathways [<xref ref-type="bibr" rid="pntd.0005268.ref039">39</xref>]. AKT phosphorylates downstream substrates to regulate cell growth, proliferation, apoptosis, senescence, and other processes [<xref ref-type="bibr" rid="pntd.0005268.ref040">40</xref>]. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Fu%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26360782" xlink:type="simple">Cong Fu</ext-link> et al. found that P-AKT expression was down-regulated during the process of cellular senescence induced by H<sub>2</sub>O<sub>2</sub> [<xref ref-type="bibr" rid="pntd.0005268.ref041">41</xref>]. Studies demonstrated that AKT phosphorylated FoxO proteins, leading to the negative FoxO regulation via triggering its nuclear exclusion [<xref ref-type="bibr" rid="pntd.0005268.ref021">21</xref>]. In addition, AKT can also promote the degradation of P27 [<xref ref-type="bibr" rid="pntd.0005268.ref042">42</xref>]. In the present study, our results showed that the expression of P-AKT was inhibited by the SEA stimulation (<xref ref-type="fig" rid="pntd.0005268.g001">Fig 1</xref>).</p>
<p>In conclusion, SEA might slow down the progression of liver fibrosis by promoting HSCs senescence through the FoxO3a/SKP2/P27 pathway. Our previous and present findings provide evidence supporting a possible mechanism by which SEA induces senescence in LX-2 cells (<xref ref-type="fig" rid="pntd.0005268.g005">Fig 5</xref>) and these provide a potential target of the clinical research of liver fibrosis.</p>
<fig id="pntd.0005268.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0005268.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Proposed mechanisms by which SEA could induce senescence in LX-2 cells.</title>
<p>SEA could induce senescence in LX-2 cells, partly through STAT3/P53/P21 pathway and partly through FoxO3a/SKP2/P27 pathway.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0005268.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec020">
<title>Supporting Information</title>
<supplementary-material id="pntd.0005268.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pntd.0005268.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>FoxO3a is implicated in the SEA-induced LX-2 cells senescence.</title>
<p>Nuclear accumulation of FoxO3a was detected by immunofluorescence staining and visualized under oil lens of fluorescent microscopy (original magnification 1000×).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pntd.0005268.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duval</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Moreno-Cuevas</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>González-Garza</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Maldonado-Bernal</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Cruz-Vega</surname> <given-names>DE</given-names></name> (<year>2015</year>) <article-title>Liver Fibrosis and Mechanisms of the Protective Action of Medicinal Plants Targeting Inflammation and the Immune Response</article-title>. <source>International Journal of Inflammation</source> <volume>2015</volume>: <fpage>943497</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2015/943497" xlink:type="simple">10.1155/2015/943497</ext-link></comment> <object-id pub-id-type="pmid">25954568</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ellis</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Mann</surname> <given-names>DA</given-names></name> (<year>2012</year>) <article-title>Clinical evidence for the regression of liver fibrosis</article-title>. <source>Journal of hepatology</source> <volume>56</volume>: <fpage>1171</fpage>–<lpage>1180</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jhep.2011.09.024" xlink:type="simple">10.1016/j.jhep.2011.09.024</ext-link></comment> <object-id pub-id-type="pmid">22245903</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tian</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>XY</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>YF</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>QM</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>SJ</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Schistosoma japonicum scFv-IL18 fusion DNA ameliorates hepatic fibrosis in schistosomiasis-infected mice via improving local concentration of IL-18 in liver</article-title>. <source>Exp Parasitol</source> <volume>134</volume>: <fpage>447</fpage>–<lpage>454</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.exppara.2013.05.002" xlink:type="simple">10.1016/j.exppara.2013.05.002</ext-link></comment> <object-id pub-id-type="pmid">23684910</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kong</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zheng</surname> <given-names>S</given-names></name> (<year>2013</year>) <article-title>Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential</article-title>. <source>Biomed Pharmacother</source> <volume>67</volume>: <fpage>246</fpage>–<lpage>250</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.biopha.2012.10.002" xlink:type="simple">10.1016/j.biopha.2012.10.002</ext-link></comment> <object-id pub-id-type="pmid">23201010</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bartley</surname> <given-names>PB</given-names></name>, <name name-style="western"><surname>Ramm</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Ruddell</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis</article-title>. <source>Int J Parasitol</source> <volume>36</volume>: <fpage>993</fpage>–<lpage>1001</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijpara.2006.04.015" xlink:type="simple">10.1016/j.ijpara.2006.04.015</ext-link></comment> <object-id pub-id-type="pmid">16806222</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Foo</surname> <given-names>NP</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>YJ</given-names></name> (<year>2011</year>) <article-title>alpha-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-beta</article-title>. <source>Toxicology</source> <volume>282</volume>: <fpage>39</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tox.2011.01.009" xlink:type="simple">10.1016/j.tox.2011.01.009</ext-link></comment> <object-id pub-id-type="pmid">21251946</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>X</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>Expression of Septin4 in Schistosoma japonicum-infected mouse livers after praziquantel treatment</article-title>. <source>Parasites &amp; vectors</source> <volume>8</volume>: <fpage>19</fpage>.</mixed-citation></ref>
<ref id="pntd.0005268.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedman</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Bansal</surname> <given-names>MB</given-names></name> (<year>2006</year>) <article-title>Reversal of hepatic fibrosis—fact or fantasy?</article-title> <source>Hepatology</source> <volume>43</volume>.</mixed-citation></ref>
<ref id="pntd.0005268.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedman</surname> <given-names>SL</given-names></name> (<year>2008</year>) <article-title>Hepatic fibrosis—overview</article-title>. <source>Toxicology</source> <volume>254</volume>: <fpage>120</fpage>–<lpage>129</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tox.2008.06.013" xlink:type="simple">10.1016/j.tox.2008.06.013</ext-link></comment> <object-id pub-id-type="pmid">18662740</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krizhanovsky</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Yon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dickins</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Hearn</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Simon</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Senescence of Activated Stellate Cells Limits Liver Fibrosis</article-title>. <source>Cell</source> <volume>134</volume>: <fpage>657</fpage>–<lpage>667</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2008.06.049" xlink:type="simple">10.1016/j.cell.2008.06.049</ext-link></comment> <object-id pub-id-type="pmid">18724938</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Campisi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>d'Adda di Fagagna</surname> <given-names>F</given-names></name> (<year>2007</year>) <article-title>Cellular senescence: when bad things happen to good cells</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>8</volume>: <fpage>729</fpage>–<lpage>740</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrm2233" xlink:type="simple">10.1038/nrm2233</ext-link></comment> <object-id pub-id-type="pmid">17667954</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Pan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>D</given-names></name>, <etal>et al</etal>. (<year>2016</year>) <article-title>Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway</article-title>. <source>Scientific reports</source> <volume>6</volume>: <fpage>30957</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep30957" xlink:type="simple">10.1038/srep30957</ext-link></comment> <object-id pub-id-type="pmid">27489164</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Gu Kang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>La</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>IJ</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Ablation of galectin-3 induces p27(KIP1)-dependent premature senescence without oncogenic stress</article-title>. <source>Cell Death Differ</source> <volume>21</volume>: <fpage>1769</fpage>–<lpage>1779</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/cdd.2014.88" xlink:type="simple">10.1038/cdd.2014.88</ext-link></comment> <object-id pub-id-type="pmid">24971481</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qi</surname> <given-names>XF</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>ZY</given-names></name>, <name name-style="western"><surname>Xia</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Zheng</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>H</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>FoxO3a suppresses the senescence of cardiac microvascular endothelial cells by regulating the ROS-mediated cell cycle</article-title>. <source>J Mol Cell Cardiol</source> <volume>81</volume>: <fpage>114</fpage>–<lpage>126</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.yjmcc.2015.01.022" xlink:type="simple">10.1016/j.yjmcc.2015.01.022</ext-link></comment> <object-id pub-id-type="pmid">25655933</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ido</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Duranton</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lan</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Weikel</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Breton</surname> <given-names>L</given-names></name>, <etal>et al</etal>. (<year>2015</year>) <article-title>Resveratrol Prevents Oxidative Stress-Induced Senescence and Proliferative Dysfunction by Activating the AMPK-FOXO3 Cascade in Cultured Primary Human Keratinocytes</article-title>. <source>PLoS ONE</source> <volume>10</volume>: <fpage>e0115341</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0115341" xlink:type="simple">10.1371/journal.pone.0115341</ext-link></comment> <object-id pub-id-type="pmid">25647160</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Imai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hanyu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hori</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sato</surname> <given-names>S</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch</article-title>. <source>Cell reports</source> <volume>7</volume>: <fpage>194</fpage>–<lpage>207</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2014.03.006" xlink:type="simple">10.1016/j.celrep.2014.03.006</ext-link></comment> <object-id pub-id-type="pmid">24703840</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Nardella</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SW</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence</article-title>. <source>Nature</source> <volume>464</volume>: <fpage>374</fpage>–<lpage>379</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature08815" xlink:type="simple">10.1038/nature08815</ext-link></comment> <object-id pub-id-type="pmid">20237562</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>HK</given-names></name> (<year>2012</year>) <article-title>Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis</article-title>. <source>Chinese journal of cancer</source> <volume>31</volume>: <fpage>169</fpage>–<lpage>177</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5732/cjc.011.10319" xlink:type="simple">10.5732/cjc.011.10319</ext-link></comment> <object-id pub-id-type="pmid">22200179</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Gu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Schistosoma japonicum soluble egg antigens induce apoptosis and inhibit activation of hepatic stellate cells: a possible molecular mechanism</article-title>. <source>Int J Parasitol</source> <volume>44</volume>: <fpage>217</fpage>–<lpage>224</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijpara.2013.11.003" xlink:type="simple">10.1016/j.ijpara.2013.11.003</ext-link></comment> <object-id pub-id-type="pmid">24487000</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Cui</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Yun</surname> <given-names>HH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HY</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells</article-title>. <source>Cell Death Dis</source> <volume>5</volume>: <fpage>e1537</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/cddis.2014.501" xlink:type="simple">10.1038/cddis.2014.501</ext-link></comment> <object-id pub-id-type="pmid">25412315</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dobson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ramakrishnan</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kaplun</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Balan</surname> <given-names>V</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Bimodal regulation of FoxO3 by AKT and 14-3-3</article-title>. <source>Biochim Biophys Acta</source> <volume>1813</volume>: <fpage>1453</fpage>–<lpage>1464</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbamcr.2011.05.001" xlink:type="simple">10.1016/j.bbamcr.2011.05.001</ext-link></comment> <object-id pub-id-type="pmid">21621563</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ewald</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Jarrard</surname> <given-names>DF</given-names></name> (<year>2012</year>) <article-title>Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer</article-title>. <source>Transl Oncol</source> <volume>5</volume>: <fpage>278</fpage>–<lpage>287</lpage>. <object-id pub-id-type="pmid">22937180</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Jeon</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JM</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells</article-title>. <source>Br J Pharmacol</source> <volume>171</volume>: <fpage>4820</fpage>–<lpage>4830</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/bph.12590" xlink:type="simple">10.1111/bph.12590</ext-link></comment> <object-id pub-id-type="pmid">24467283</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ramachandran</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Iredale</surname> <given-names>JP</given-names></name> (<year>2009</year>) <article-title>Reversibility of liver fibrosis</article-title>. <source>Ann Hepatol</source> <volume>8</volume>: <fpage>283</fpage>–<lpage>291</lpage>. <object-id pub-id-type="pmid">20009126</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kitano</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bloomston</surname> <given-names>PM</given-names></name> (<year>2016</year>) <article-title>Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis</article-title>. <source>Journal of Clinical Medicine</source> <volume>5</volume>: <fpage>38</fpage>.</mixed-citation></ref>
<ref id="pntd.0005268.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayashi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Itoh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Isoda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kondoh</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kawase</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Fucoidan partly prevents CCl(4)-induced liver fibrosis</article-title>. <source>European Journal of Pharmacology</source> <volume>580</volume>: <fpage>380</fpage>–<lpage>384</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejphar.2007.11.015" xlink:type="simple">10.1016/j.ejphar.2007.11.015</ext-link></comment> <object-id pub-id-type="pmid">18068155</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hyun</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rao</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>SY</given-names></name>, <etal>et al</etal>. (<year>2016</year>) <article-title>MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression</article-title>. <source>Nature Communications</source> <volume>7</volume>: <fpage>10993</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms10993" xlink:type="simple">10.1038/ncomms10993</ext-link></comment> <object-id pub-id-type="pmid">27001906</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Monzon</surname> <given-names>RI</given-names></name>, <name name-style="western"><surname>Lau</surname> <given-names>LF</given-names></name> (<year>2013</year>) <article-title>Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts</article-title>. <source>Molecular and cellular biology</source> <volume>33</volume>: <fpage>2078</fpage>–<lpage>2090</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/MCB.00049-13" xlink:type="simple">10.1128/MCB.00049-13</ext-link></comment> <object-id pub-id-type="pmid">23508104</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kong</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hong</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Bertola</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice</article-title>. <source>Hepatology</source> <volume>56</volume>: <fpage>1150</fpage>–<lpage>1159</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hep.25744" xlink:type="simple">10.1002/hep.25744</ext-link></comment> <object-id pub-id-type="pmid">22473749</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fischer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Quaas</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Steiner</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Engeland</surname> <given-names>K</given-names></name> (<year>2016</year>) <article-title>The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes</article-title>. <source>Nucleic Acids Res</source> <volume>44</volume>: <fpage>164</fpage>–<lpage>174</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkv927" xlink:type="simple">10.1093/nar/gkv927</ext-link></comment> <object-id pub-id-type="pmid">26384566</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Xia</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Cao</surname> <given-names>H</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>p53/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients</article-title>. <source>Clinical &amp; developmental immunology</source> <volume>2013</volume>: <fpage>134243</fpage>.</mixed-citation></ref>
<ref id="pntd.0005268.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mirzayans</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Andrais</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hansen</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Murray</surname> <given-names>D</given-names></name> (<year>2012</year>) <article-title>Role of p16(INK4A) in Replicative Senescence and DNA Damage-Induced Premature Senescence in p53-Deficient Human Cells</article-title>. <source>Biochem Res Int</source> <volume>2012</volume>: <fpage>951574</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2012/951574" xlink:type="simple">10.1155/2012/951574</ext-link></comment> <object-id pub-id-type="pmid">22924132</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Young</surname> <given-names>AP</given-names></name>, <name name-style="western"><surname>Schlisio</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Minamishima</surname> <given-names>YA</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>L</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400</article-title>. <source>Nature cell biology</source> <volume>10</volume>: <fpage>361</fpage>–<lpage>369</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncb1699" xlink:type="simple">10.1038/ncb1699</ext-link></comment> <object-id pub-id-type="pmid">18297059</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuo</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Giam</surname> <given-names>CZ</given-names></name> (<year>2006</year>) <article-title>Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence</article-title>. <source>The EMBO journal</source> <volume>25</volume>: <fpage>1741</fpage>–<lpage>1752</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.emboj.7601054" xlink:type="simple">10.1038/sj.emboj.7601054</ext-link></comment> <object-id pub-id-type="pmid">16601696</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caraballo</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Acosta</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Cortés</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Albajar</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gómez-Casares</surname> <given-names>MT</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle</article-title>. <source>Oncotarget</source> <volume>5</volume>: <fpage>4694</fpage>–<lpage>4708</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.18632/oncotarget.2100" xlink:type="simple">10.18632/oncotarget.2100</ext-link></comment> <object-id pub-id-type="pmid">25051361</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Choe</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Shin</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HS</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma</article-title>. <source>Experimental &amp; molecular medicine</source> <volume>46</volume>: <fpage>e97</fpage>.</mixed-citation></ref>
<ref id="pntd.0005268.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Yuan</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Luo</surname> <given-names>Q</given-names></name>, <etal>et al</etal>. (<year>2016</year>) <article-title>SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation</article-title>. <source>Oncotarget</source>.</mixed-citation></ref>
<ref id="pntd.0005268.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kyoung Kim</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kyoung Kim</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>IH</given-names></name>, <name name-style="western"><surname>Baek</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SR</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Down-regulation of a forkhead transcription factor, FOXO3a, accelerates cellular senescence in human dermal fibroblasts</article-title>. <source>J Gerontol A Biol Sci Med Sci</source> <volume>60</volume>: <fpage>4</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">15741276</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shimura</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sasatani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kamiya</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kawai</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Inaba</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2016</year>) <article-title>Mitochondrial reactive oxygen species perturb AKT/cyclin D1 cell cycle signaling via oxidative inactivation of PP2A in lowdose irradiated human fibroblasts</article-title>. <source>Oncotarget</source> <volume>7</volume>: <fpage>3559</fpage>–<lpage>3570</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.18632/oncotarget.6518" xlink:type="simple">10.18632/oncotarget.6518</ext-link></comment> <object-id pub-id-type="pmid">26657292</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ma</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Nyamtsengel</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Bao</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Lian</surname> <given-names>MY</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>WP</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Overexpression of protein kinase B/AKT induces phosphorylation of p70S6K and 4E-BP1 in goat fetal fibroblasts</article-title>. <source>Genetics and molecular research: GMR</source> <volume>13</volume>: <fpage>9931</fpage>–<lpage>9938</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4238/2014.November.27.22" xlink:type="simple">10.4238/2014.November.27.22</ext-link></comment> <object-id pub-id-type="pmid">25501204</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Yao</surname> <given-names>Y</given-names></name> (<year>2015</year>) <article-title>Bradykinin inhibits oxidative stress-induced senescence of endothelial progenitor cells through the B2R/AKT/RB and B2R/EGFR/RB signal pathways</article-title>. <source>Oncotarget</source> <volume>6</volume>: <fpage>24675</fpage>–<lpage>24689</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.18632/oncotarget.5071" xlink:type="simple">10.18632/oncotarget.5071</ext-link></comment> <object-id pub-id-type="pmid">26360782</object-id></mixed-citation></ref>
<ref id="pntd.0005268.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davaadelger</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Duan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Perez</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Gitelis</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Maki</surname> <given-names>CG</given-names></name> (<year>2016</year>) <article-title>Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor</article-title>. <source>Oncotarget</source>.</mixed-citation></ref>
</ref-list>
</back>
</article>